Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Bio Innovations Inc.
|
| gptkbp:awards |
Best Biotech Company 2020
|
| gptkbp:ceo |
gptkb:John_Doe
|
| gptkbp:client |
gptkb:Non-profit_organizations
Government agencies Research institutions Major pharmaceutical companies |
| gptkbp:clinical_trial |
Ongoing
|
| gptkbp:collaborations |
Academic institutions
|
| gptkbp:community_involvement |
Educational programs
Local health initiatives |
| gptkbp:employees |
50-100
|
| gptkbp:financials |
Privately held
Revenue growth year over year |
| gptkbp:focus |
Regenerative medicine
|
| gptkbp:founded |
gptkb:2001
|
| gptkbp:headquarters |
gptkb:United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Apex Biologics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:invention |
Multiple patents in biotechnology
|
| gptkbp:investment |
Venture Capital Firms
|
| gptkbp:location |
gptkb:California
|
| gptkbp:market_position |
gptkb:Europe
gptkb:Asia gptkb:North_America |
| gptkbp:mission |
To advance healthcare through innovative biologics.
|
| gptkbp:partnerships |
Various pharmaceutical companies
|
| gptkbp:products |
Gene therapies
Cell therapies |
| gptkbp:regulatory_compliance |
FDA approved
|
| gptkbp:research_areas |
Stem cell research
Tissue engineering |
| gptkbp:services |
gptkb:Research_and_development
Contract manufacturing |
| gptkbp:specializes_in |
Biologics
|
| gptkbp:subsidiaries |
Apex Therapeutics
|
| gptkbp:sustainability_practices |
Eco-friendly manufacturing
Waste reduction initiatives |
| gptkbp:technology |
Advanced biomanufacturing techniques
Cell culture systems Genetic engineering tools Analytical methods for biologics. |
| gptkbp:values |
gptkb:Innovation
gptkb:collaboration Integrity Excellence |
| gptkbp:vision |
To be a leader in the biotechnology industry.
|
| gptkbp:website |
www.apexbiologics.com
|
| gptkbp:bfsParent |
gptkb:Sartorius_Stedim_Biotech
|
| gptkbp:bfsLayer |
5
|